Define the problem
Specify the population, setting, hydration concern and outcome that matters.
Science
Clinical Development
Clinical hydration claims need evidence from the right product, population and setting. Our development work separates research questions, regulated trials, product authorization and clinical care.
Research is not careA study answers a research question. It does not replace diagnosis or treatment.
Study type mattersObservational and interventional studies answer different questions and carry different requirements.
Authorization has limitsA Natural Product Number covers labelled use. It does not prove every proposed clinical application.
Why clinical development
Mechanism is a starting point, not a clinical claim
Hydration physiology helps explain why fluid, electrolytes and glucose matter. Showing that a specific product improves a clinical outcome requires product-specific evidence in the population and setting being discussed.
That is the purpose of clinical development: define the question, choose the right study and expand claims only when the evidence and regulatory basis support them.
Development pathway
From question to evidence
Test feasibility
Confirm that recruitment, preparation, measurements and workflow are practical before a larger study.
Write the protocol first
Predefine the intervention, comparator where appropriate, outcomes, safety monitoring and analysis.
Get the required approvals
Human research may require Research Ethics Board review and, for applicable natural health product trials, Health Canada authorization.
Report what was actually shown
Keep conclusions within the studied formulation, dose, population and care context.
Research, care and regulation
Keep the boundaries clear
Clinical care is organized around an individual patient. Research follows a protocol designed to produce generalizable knowledge. Participation in a study should not be presented as a treatment recommendation.
Health Canada identifies licensed natural health products with an eight-digit Natural Product Number. That authorization applies to labelled conditions of use. A clinical trial can ask a different question and may require a separate authorization pathway.
Where the work lives
Three parts of the clinical program
Clinical Program
Research questions, governance and the evidence needed to move forward.
Clinical Program →Pilot Studies
Early studies that test measurements, workflows and feasibility before larger conclusions.
Pilot Studies →Healthcare Applications
Healthcare settings where hydration may matter, framed as questions rather than broad treatment claims.
Healthcare Applications →Ethics & transparency
Plan the study before celebrating the result
Consent in human research should be free, informed and ongoing. Applicable regulated trials should also be registered and their results disclosed in line with current requirements.
Best Hydrate will name project-specific approvals only when they are verified and appropriate for public disclosure.
Regulatory and ethics references
- Health Canada. Clinical Trials for Natural Health Products.
- Health Canada. Clinical Trials Forms and Template, Natural Health Products.
- Health Canada. Guidance on the registration of clinical trials and public disclosure of results. Effective July 29, 2026.
- TCPS 2 (2022), Chapter 3: The Consent Process.
- Health Canada. About Natural Health Products and Natural Product Numbers.
This page describes a development approach, not an announcement that a particular Best Hydrate clinical trial has received ethics or Health Canada authorization.
Clinical Development
Clinical Program
Our clinical program defines the questions, measurements and decision rules needed to study oral hydration responsibly. It is a research framework, not a claim that Best Hydrate is already standard clinical care.
Start with the use caseDefine the population, setting, hydration problem and outcome before considering a product claim.
Feasibility firstPreparation, adherence, measurements and workflow need to work before a larger study makes sense.
Predefine the next stepResults should determine whether to refine, stop, repeat or advance.
Program pillars
What we need to understand
Measurement
Which hydration measures are practical and interpretable in the population being studied?
Preparation & tolerance
Can the product be prepared consistently, consumed as intended and tolerated?
Clinical relevance
Are the outcomes meaningful to the care question, not just easy to measure?
Implementation
Can the approach fit real workflows, staffing, education and access?
Evidence ladder
Advance only when the previous question is answered
Rationale asks whether the idea is plausible. Feasibility asks whether the study can work. Safety and tolerability ask whether the intervention can be used as planned. Efficacy asks whether it changes a predefined outcome. Implementation asks whether any benefit survives real-world use.
Later-stage clinical language should not outrun the strongest evidence available.
Governance
The protocol determines the requirements
Human research should define investigator and sponsor roles, data custody, safety reporting, analysis, conflicts of interest and publication plans before the work begins.
Research Ethics Board and regulatory requirements depend on what the study actually does. Calling a project “observational” or “pilot” does not change requirements triggered by the protocol.
Decision gates
What happens next?
| Stage | Main question | Possible next step |
|---|---|---|
| Methods / feasibility | Can the protocol be executed and measured reliably? | Refine methods, reduce burden or advance. |
| Pilot | Are recruitment, preparation, adherence and safety monitoring workable? | Stop, redesign, narrow or plan a larger study. |
| Controlled evaluation | Does the intervention change the prespecified outcome? | Replicate, refine or stop. |
| Implementation | Can it be delivered appropriately in real care? | Refine workflow, access and eligibility. |
Current stage
Methods and feasibility come first
Our public clinical-development language remains conservative while measurement, governance and pilot-study foundations are being built.
Program references
- Health Canada. Clinical Trials for Natural Health Products.
- Health Canada. Clinical Trials Forms and Template.
- TCPS 2 (2022), Chapter 3: Consent Process.
- Barley OR, Chapman DW, Abbiss CR. Reviewing the current methods of assessing hydration in athletes. JISSN. 2020.
This page describes the program framework. It does not mean every study stage shown here is underway or approved.
Clinical Development
Pilot Studies
Pilot studies test whether a larger study is practical and how it should be designed. They are for feasibility, not for turning small early results into efficacy claims.
Feasibility firstCan the future study be done well, and should it proceed?
Use progression criteriaRecruitment, completion, data quality, adherence and tolerance should guide the next step.
Keep status explicitConcept, planned, approved, recruiting, completed and analyzed are different stages.
Current public pilot portfolio
Questions in methods and feasibility development
| Pilot concept | Status | Main question |
|---|---|---|
| Multi-measure hydration assessment | Protocol development / planned | Can complementary hydration measures be collected reliably without over-relying on one spot value? |
| Preparation and tolerability workflow | Methods development | Can preparation, timing, intake, adherence and gastrointestinal tolerance be recorded consistently? |
| Clinical observation framework | Exploratory design | Which routine observations could help define later clinical questions? |
What pilots are for
Answer design questions before efficacy questions
Useful pilot outputs include recruitment, retention, sample completeness, adherence, acceptability, protocol deviations and whether planned outcomes can be measured consistently.
A small apparent difference can be interesting, but a pilot that is not designed or powered for efficacy should not be marketed as proof of effectiveness.
Progression criteria
Decide in advance what would make a pilot advance, change or stop
Recruitment
Can the intended population be identified and enrolled at a workable rate?
Protocol completion
Can participants and staff follow preparation, timing, sampling and follow-up?
Data quality
Are measurements complete and consistent enough for the planned analysis?
Safety & tolerance
Are symptoms, adverse events and stopping reasons captured clearly?
Research governance
“Pilot” is not an exemption
Ethics and regulatory requirements depend on the actual study activities, including intervention assignment, sampling and product conditions of use.
Public descriptions should follow the finalized protocol classification, not try to define it through marketing language.
Clinical Development
See where pilot work fits
Follow the broader clinical program or review the status of current research.
Selected methods references
- Eldridge SM et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot and Feasibility Studies. 2016.
- Eldridge SM et al. CONSORT extension for randomised pilot and feasibility trials. BMJ. 2016;355:i5239.
- Health Canada. Clinical Trials for Natural Health Products.
- Barley OR, Chapman DW, Abbiss CR. Reviewing the current methods of assessing hydration in athletes. JISSN. 2020.
These are public research directions, not completed studies. Specific protocols, sites, sample sizes and approvals should be added only when verified.
Clinical Development
Healthcare Applications
Hydration can matter in healthcare, but the right approach depends on the cause, severity and the person’s medical context. These are research and care settings, not universal Best Hydrate treatment indications.
Cause comes firstLow intake, illness, medications and organ function can create very different fluid problems.
Severity changes the planOral fluids may help in some situations. Severe illness or unsafe swallowing requires medical assessment.
Use products as labelledA possible healthcare use is not automatically an authorized clinical indication.
Clinical framing
“Hydration” is not one diagnosis
Fluid balance can change because of poor intake, gastrointestinal losses, fever, medication, kidney or heart disease and many other factors. The correct response depends on the cause and the person’s overall condition.
General hydration support is different from diagnosing or treating dehydration, electrolyte disorders or disease.
Application areas
Where hydration questions come up
Illness & fluid loss
Vomiting, diarrhoea, fever and poor intake can increase losses. Mild support, therapeutic oral rehydration solution and medical treatment are not interchangeable.
Recovery & rehabilitation
Mobility, appetite, medications, swallowing and access to drinks can affect hydration during recovery.
Recovery & Rehabilitation →Active aging
Thirst, kidney function, mobility, medications and dependence on others can all affect hydration in older adults.
Active Aging →Clinician-guided hydration
Some conditions require clinician-directed fluid, sodium, potassium or volume targets rather than a standard consumer recommendation.
Older adults
Risk can rise, but generic advice is not enough
Older adults may have reduced thirst, lower total-body water reserves, mobility barriers, swallowing difficulty or medication-related fluid concerns. Signs of dehydration can also be nonspecific.
That makes hydration important, but “drink more” can be inappropriate for people with fluid restrictions, heart failure, advanced kidney disease or other prescribed plans.
Oral rehydration
Consumer hydration and therapeutic oral rehydration are different
World Health Organization reduced-osmolarity oral rehydration salts are a defined therapeutic formulation used for diarrhoeal dehydration. An electrolyte drink may share ingredients without being equivalent in formulation, intended use or evidence.
Best Hydrate’s current product should be used according to its authorized label. Additional clinical questions belong in appropriately designed research.
When self-directed drinking is not enough
Situations that need clinical judgment
Fluid or sodium restrictions
Heart, kidney, liver or endocrine conditions can change safe fluid and electrolyte targets.
Unsafe swallowing or altered consciousness
People who cannot drink safely, are significantly confused or cannot keep fluids down need assessment rather than repeated self-treatment.
Severe or persistent losses
Ongoing losses, very low intake, marked weakness or other signs of significant illness require evaluation of the cause and severity.
Research standard
Specific population. Specific question. Specific evidence.
Healthcare hydration applications should be studied separately rather than grouped under a broad “medical hydration” claim.
Selected references
- Hydration Status in Older Adults: Current Knowledge and Future Challenges. Nutrients. 2023.
- A multidisciplinary consensus on dehydration: definitions, diagnostic methods and clinical implications.
- WHO/UNICEF. Oral Rehydration Salts: Production of the New ORS.
- Health Canada. About Natural Health Products and Natural Product Numbers.
- Health Canada. Clinical Trials for Natural Health Products.
This page is educational. It does not replace diagnosis, clinician-directed fluid management, emergency assessment or the authorized Best Hydrate product label.
